Test-retest repeatability of data-driven radiomic features derived from a deep-learning model: Diffusion-weighted MRI of soft-tissue sarcoma
Timothy S.H. Mun, Imogen Thrussell, Jessica M. Winfield, Amani Arthur, David J. Collins, Dow-Mu Koh, Paul H. Huang, Simon J. Doran, Christina Messiou, Matthew D. Blackledge. Joint Annual Meeting International Society for Magnetic Resonance in Medicine (ISMRM) - European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) and International Society for MR Radiographers & Technologists (ISMRT) 31st Annual Meeting 9 May 2022 (Accepted Paper)
OsiriXgrpc: Rapid development and deployment of state-of-the-art artificial intelligence for clinical practice
Timothy S.H. Mun, Richard Holbrey, Sue Chua, Paul H. Huang, Christina Messiou, Simon J. Doran, Matthew D. Blackledge. Association for the Advancement of Artificial Intelligence (AAAI) 2022, AI to Accelerate Science and Engineering (AI2ASE) Workshop 28 February 2022 (Accepted Paper)
Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
William G. J. Kerrison, Alexander T. J. Lee, Khin Thwa, Robin L. Jones, Paul H. Huang. Biomedicines 28 February 2022, 10(3):573. https://doi.org/10.3390/biomedicines10030573
Integrating the OHIF Viewer into XNAT: Achievements, Challenges and Prospects for Quantitative Imaging Studies
Simon J. Doran, Mohammad Al Sa’d, James A. Petts, James Darcy, Kate Alpert, Woonchan Cho, Lorena Escudero Sanchez, Sachidanand Alle, Ahmed El Harouni, Brad Genereaux, Erik Ziegler, Gordon J. Harris, Eric O. Aboagye, Evis Sala, Dow-Mu Koh and Dan Marcus. Tomography 11 February 2022, 8(1):497-512. https://doi.org/10.3390/tomography8010040
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
Jean-Yves Blay, Nadia H. Muñiz, Julien Bollard, Samuel Aguiar, Martin Angel, Beatriz Araya, Ronald Badilla-González, Daniel Bernabeu, Fernando A.B. Campos, Claudia H.S. Caro-Sánchez, Berenice Carvajal, Alvaro Carvajal Montoya, Sandro Casavilca-Zambrano, Victor Castro-Oliden, Matías Chacón, Miguel Clara, Paola Collini, Raquel Correa Genoroso, Felipe D. Costa, Mario Cuellar, Angelo P. dei Tos, Hugo R. Dominguez Malagon, Davide M. Donati, Armelle Dufresne, Mikael Eriksson, Macarena Farias-Loza, P. Fernandez, Anna M. Frezza, Tommaso Frisoni, Dorian Y. Garcia-Ortega, Hans Gelderblom, Francois Gouin, María C. Gómez-Mateo, Alessandro Gronchi, Juan C. Haro-Varas, Lourdes Huanca, Natalia Jiménez-Brenes, Marie Karanian, Bernd Kasper, Bruna B. Lopes David, Antonio Lopez-Pousa, Guido Lutter, Héctor Martinez-Said, Jorge L. Martinez-Tlahuel, Celso A.L.D. Mello, Jose M. Morales-Pérez, David S. Moura, Antonio G. Nascimento, Eduardo J. Ortiz-Cruz, Emanuela Palmerini, Shreyaskumar Patel, Yanina Pfluger, Salvatore Provenzano, Alberto Righi, Andrés Rodriguez, Rafael S. Salas, Tiago T.G. Santos, Katia Scotlandi, Tomas J. Soule, Silvia Stacchiotti, Claudia Valverde, Federico Waisberg, Esteban Zamora Estrada, Javier Martín-Broto. Cancer Treatment Reviews 1 January 2022, 102:102312. https://doi.org/10.1016/j.ctrv.2021.102312
Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas
Maria Lopez-Alvarez, Cristina Gonzalez-Aguilera, David S. Moura, Paloma Sanchez-Bustos, Jose L. Mondaza-Hernandez, Rafael Ramos, Carolina Castilla, Elena Blanco-Alcaina, Nadia Hindi, Javier Martín-Broto. Efficacy of eribulin plus gemcitabine combination in L-sarcomas. Int J Mol Sci. 2022 Dec 30;24(1):680. https://doi.org/10.3390/ijms24010680
Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
Alessandrini I, Percio S, Zuco V, Naghshineh E, Stacchiotti S, Gronchi A, Pasquali S, Zaffaroni N, Folini M. Telomeres as Therapeutic Targets in Dedifferentiated Liposarcoma. Cancers. 2022 May 25;14(11):2624. https://doi.org/10.3390/cancers14112624
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
Cassinelli G, Pasquali S, Lanzi C. Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers. Front Oncol. 2022 Sep 2; 12:965261 https://doi.org/10.3389/fonc.2022.965261